The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Cardiovascular and Pulmonary Research on E-Cigarettes (R01) |
93.396, 93.837, 93.838 |
RFA-HL-18-024 |
| Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03) |
93.855, 93.856 |
PAR-17-439 |
| Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp) |
93.853 |
PA-17-442 |
| Tailoring Cardiac Rehabilitation to Enhance Participation of Older Adults (R01) |
93.866 |
RFA-AG-18-016 |
| Assay development and screening for discovery of chemical probes or therapeutic agents (R01) |
93.173, 93.279, 93.395, 93.855, 93.856 |
PAR-17-438 |
| Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Enhanced Diversity Clinical Groups (U01) |
93.172 |
RFA-HG-17-009 |
| Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Clinical Groups (U01) |
93.172 |
RFA-HG-17-008 |
| National Centers for Translational Research in Reproduction and Infertility (P50) |
93.865 |
RFA-HD-18-008 |
| Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Coordinating Center |
93.172 |
RFA-HG-17-010 |
| Synthetic Biology for Engineering Applications (R01) |
93.213, 93.286, 93.394 |
PAR-17-334 |
| Discovery of in vivo Chemical Probes for Novel Brain Targets (R01) |
93.173, 93.242, 93.273, 93.279, 93.867 |
PAR-17-336 |
| Population Dynamics Centers Research Infrastructure Program FY 2018 (P2C) |
93.865 |
RFA-HD-18-013 |
| Discovery of cell-based Chemical Probes for Novel Brain Targets (R21) |
93.173, 93.242, 93.866, 93.867 |
PAR-17-335 |
| Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) |
93.855, 93.856 |
PAR-17-333 |
| Small Grants on Primary Immunodeficiency Diseases (R03) |
93.855, 93.856 |
PAR-17-332 |
| CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) |
93.865 |
RFA-HD-18-012 |
| Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) |
93.395 |
PAR-17-331 |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00) |
93.855, 93.856 |
PAR-17-329 |
| Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) |
93.396 |
PA-17-330 |
| Tobacco Regulatory Science Small Grant Program for New Investigators (R03) |
93.077 |
RFA-OD-17-012 |
| Tobacco Regulatory Science (R21) |
93.077 |
RFA-OD-17-014 |
| Tobacco Regulatory Science (R01) |
93.077 |
RFA-OD-17-013 |
| NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp) |
93.242 |
PA-17-328 |
| Central Neural Mechanisms of Age-Related Hearing Loss (R01) |
93.173, 93.866 |
RFA-AG-18-017 |
| First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01) |
93.242 |
PAR-17-327 |
| Re-Competition of Global Network for Womens and Childrens Health Research (UG1) |
93.865 |
RFA-HD-18-009 |
| Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.279, 93.286, 93.350, 93.853, 93.866 |
PA-17-326 |
| The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24) |
93.172 |
RFA-HG-17-011 |
| BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EY-17-002 |
| Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-18-018 |
| Development of a Device to Objectively Measure Pain (R41/R42) |
93.279 |
RFA-DA-18-013 |
| Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33) |
93.233, 93.837, 93.838, 93.839 |
RFA-HL-18-019 |
| Development of a Device to Objectively Measure Pain (R43/R44) |
93.279 |
RFA-DA-18-012 |
| Consortium Linking Oncology with Thrombosis (CLOT) (U01) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-18-021 |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) |
93.113, 93.172, 93.173, 93.307, 93.399, 93.853, 93.866 |
PA-17-325 |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) |
93.113, 93.172, 93.173, 93.307, 93.399, 93.853, 93.855, 93.866 |
PA-17-323 |
| Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) |
93.113, 93.172, 93.173, 93.399, 93.855, 93.856, 93.866, 93.989 |
PA-17-324 |
| Expanding Genome Integrity Assays to Population Studies (U01) |
93.113, 93.399 |
RFA-ES-17-006 |
| Mobile Monitoring of Cognitive Change (U2C) |
93.866 |
RFA-AG-18-012 |
| Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MRSRCs) (P50) |
93.837, 93.846, 93.853, 93.865 |
RFA-AR-18-001 |
Search Results 5361-5400 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
